NCT05321017

Brief Summary

The purpose of this study is to examine the relationship between common clinical assessments and measurements of the function of brain-spinal cord-muscle connections, and to examine the effects of training a brain-spinal cord-muscle response in individuals with incomplete spinal cord injury. A transcranial magnetic stimulator (TMS) is used for examining brain-to-muscle pathways. This stimulator produces a magnetic field for a very short period of time and indirectly stimulates brain cells with little or no discomfort. The target muscle is the wrist extensor (extensor carpi radialis) muscle that bends the wrist back. It is hypothesized that training the wrist extensor muscle response to transcranial magnetic stimulation will increase the strength of the brain-to-muscle pathway, which will improve the ability to move the arm. It is hoped that the results of this training study will help in developing therapy strategies for individuals, promoting better understanding of clinical assessments, and understanding treatments that aim to improve function recovery in people with spinal cord injury (SCI). This study requires 30 visits, and each visit will last approximately 1.5 hours.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Oct 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Oct 2021Jun 2026

Study Start

First participant enrolled

October 12, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 11, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

4.7 years

First QC Date

March 4, 2022

Last Update Submit

June 16, 2025

Conditions

Outcome Measures

Primary Outcomes (8)

  • Change in the excitability/strength of the brain-spinal cord-muscle pathway at the brain level as measured by the Motor Evoked Potential

    An increased average MEP size (mV) would indicate increased excitability/strength of the brain-spinal cord-muscle pathway

    Baseline and final training session (approximately 2.5 months)

  • Change in ability to move the arm as measured by the Action Research Arm Test (ARAT). Maximum score of 57 points

    An increase in ARAT score indicates an improvement in the ability to move the arm

    change from baseline to immediately after completing the training protocol

  • Change in ability to move the arm as measured by the Fugl-Meyer Assessment (FMA)

    An increase in the FMA score indicates better movement of the arm. Maximum score of 66 points

    change from baseline to immediately after completing the training protocol

  • Change in gross manual dexterity as measured by the Box and Block Test (BBT)

    An increased number of blocks moved in 60s indicates increased gross manual dexterity

    change from baseline to immediately after completing the training protocol

  • Change in fine motor ability and finger dexterity as measured by the Nine Hole Peg Test

    Decreased amount of time (s) to place and remove pegs in a peg board indicates improved fine motor ability and finger dexterity

    change from baseline to immediately after completing the training protocol

  • Change in strength as measured by Manual Muscle Testing (MMT)

    Increased score on MMT indicates increased strength in the muscle being tested. The examiner grades the patient's strength on a 0 to 5 scale. 0: No muscle activation; 1: Trace muscle activation, such as a twitch, without achieving full range of motion; 2: Muscle activation with gravity eliminated, achieving full range of motion; 3: Muscle activation against gravity, full range of motion; 4: Muscle activation against some resistance, full range of motion; 5: Muscle activation against examiner's full resistance, full range of motion.

    change from baseline to immediately after completing the training protocol

  • Change in sensation on the back and palm of the hand as measured by the Semmes Weinstein Monofilament Test

    Ability to detect increasingly thinner monofilaments indicates increased sensation

    change from baseline to immediately after completing the training protocol

  • Change in spasticity as measured by the Modified Ashworth Scale (mAS)

    The mAS score ranges from 0: normal muscle tone to 4: rigid in flexion or extension. A decrease in mAS indicates decreased spasticity.

    change from baseline to immediately after completing the training protocol

Study Arms (1)

MEP Wrist Extensor Up-Conditioning

EXPERIMENTAL
Behavioral: MEP Operant Up-conditioning of the Wrist Extensor

Interventions

This is a training intervention in which the brain-spinal cord-muscle pathways are strengthened in individuals with incomplete spinal cord injury. Transcranial magnetic stimulation (TMS), a type of brain stimulation, will be used to elicit a muscle response from the wrist extensor (extensor carpi radialis), the muscle the bends the wrist back.

MEP Wrist Extensor Up-Conditioning

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a history of injury to spinal cord at or above C6
  • neurologically stable (\>6 mo post SCI)
  • medical clearance to participate
  • weak wrist extension at least unilaterally
  • expectation that current medication will be maintained without change for at least 3 months. Stable use of anti-spasticity medication (e.g., baclofen, diazepam, tizanidine) is accepted. In participants with bilateral wrist extension weakness, the more severely impaired arm is studied.

You may not qualify if:

  • motoneuron injury
  • medically unstable condition
  • cognitive impairment
  • a history of epileptic seizures
  • metal implants in the cranium
  • implanted biomedical device in or above the chest (e.g., a cardiac pacemaker, cochlear implant)
  • no measurable MEP elicited in the ECR
  • unable to produce any voluntary ECR EMG activity
  • extensive use of functional electrical stimulation to the arm on a daily basis
  • pregnancy (due to changes in posture and potential medical instability).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesQuadriplegia

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Blair Dellenbach, MSOT

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Blair Dellenbach, MSOT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Occupational Therapist

Study Record Dates

First Submitted

March 4, 2022

First Posted

April 11, 2022

Study Start

October 12, 2021

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

June 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations